ストックスクリーナーアプリを入手
27.39
8.91%
2.24
アフターアワーズ：
28.05
0.66
+2.41%
前日終値:
$25.15
開ける：
$26
24時間の取引高:
544.65K
Relative Volume:
6.00
時価総額：
$1.47B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+8.86%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$25.50
$28.98
1週間の範囲:
$24.35
$28.98
52週間の値動き範囲:
$20.74
$28.98
Upstream Bio Inc Stock (UPB) Company Profile
Upstream Bio Inc (UPB) 最新ニュース
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say - Benzinga
This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Upstream Bio (NASDAQ:UPB) Earns Overweight Rating from Analysts at Piper Sandler - MarketBeat
TD Cowen bullish on Upstream Bio, bets on differentiated asthma treatment verekitug - Investing.com
Upstream Bio prices IPO at $17 per share - MSN
Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline
Septerna Shares Jump 19% After IPO Shows Biotech Still Hot - Bloomberg
CeriBell Shares Rise 47% to Lead Trio of Life Sciences IPOs - MSN
Goldman-backed drug developer Septerna raises $288 mln in US IPO - Reuters
Upstream Bio stock rallies 32% following upsized $255M IPO - MSN
Upstream Bioprocessing Market Forecast 2024: Key Global Developments - openPR
Upstream Bio Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Upstream Bio Rings the Opening Bell - Nasdaq
Warren Buffett and Biotech IPOs Highlight Recent Insider Buying - 24/7 Wall St.
Insider Trading Recap: Thursday's Top Buys and Sells in US Stocks - Investing.com
Orbimed Advisors LLC Acquires New Stake in Upstream Bio Inc - Yahoo Finance
Upstream bio director Erez Chimovits buys $14 million in shares By Investing.com - Investing.com South Africa
Upstream bio director Erez Chimovits buys $14 million in shares - Investing.com
OrbiMed Advisors LLC purchases $14 million in Upstream Bio shares - Investing.com
Some of the Major Key Players in the Continuous Bioprocessing Market are - InsightAce Analytic
Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - The Manila Times
Chronic Rhinosinusitis with Nasal Polyps Market Expected - openPR
Upstream Bio and Camp4 and Ceribell Transactions - William Blair
UPB News Today | Why did Upstream Bio stock go down today? - MarketBeat
Upstream Bio shares soar in impressive IPO - The Pharma Letter
Opening Day: Another trio of biotech IPOs make Friday debut - Yahoo Finance
HBM portfolio company Upstream Bio raises USD 255 million in successful initial public offering - Marketscreener.com
Upstream Bio Leads Life Sciences IPOs With Upsized Listing - MSN
Upstream catches aftermarket updraft, as Camp4 IPO gets muted reception - BioCentury
Finance Watch: 2024 Has Now Beaten 2023’s Total Of 21 IPOs - Scrip
Aiming to Outdo Rivals in Severe Asthma, Upstream Bio Upsizes IPO to $225M - MedCity News
Upstream Bio Shares Rise 26% to Lead Burst of Life Sciences IPOs - MSN
6 Firms Guide IPO Trio From Biotech, Medical Device Cos. - Law360
Upstream Bio Shares Jump on First Day of Trading - MarketWatch
Shares of one Mass. biotech rises, another one mostly flat, after IPOs - The Business Journals
Upstream Bio stock rallies 32% following upsized $255M IPO (NASDAQ:UPB) - Seeking Alpha
Upstream Bio valued at $1.1 billion as shares jump in Nasdaq debut - WTVB
Upstream Bio Opens At $21.50, IPO Priced At $17 By Investing.com - Investing.com Canada
Upstream Bio valued at $1.1 bln in stellar debut as healthcare IPOs heat up - TradingView
Upstream Bio, two other U.S. biotech startups price IPOs as healthcare listings rise - Reuters
Upstream Bio Prices Upsized 15M Share IPO at $17/sh - Investing.com
Upstream Bio Leads Three Life Sciences IPOs With Upsized Listing - MSN
Upstream Bio raises $255 million in US IPO - MSN
Two more Mass. biotechs raise $330M in IPOs, to debut on Nasdaq - The Business Journals
Upstream Bio Announces Pricing of Upsized Initial Public Offering - ForexTV.com
Upstream Bio Announces Pricing Of Upsized Initial Public Offering - XM
Preview: Upstream Bio, Inc Set To IPO Tomorrow - Benzinga
Upstream Bio Inc (UPB) 財務データ
Upstream Bio Inc (UPB) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):